The DOJ and HHS reestablish the False Claims Act Working Group to enhance enforcement against healthcare fraud and abuse in federal programs, emphasizing compliance and whistleblower roles.

A federal court has blocked key staffing requirements in the 2024 CMS rule for long-term care facilities, creating regulatory uncertainty amid ongoing litigation and legislative attempts to pause implementation until 2034.

Dan Schuleman, CEO of Qumis, leads AI-powered advances in insurance policy intelligence, enhancing digital transformation in financial services and regulatory compliance.

BNP Paribas completed the €5.1 billion acquisition of AXA Investment Managers, enhancing its asset management and ETF platform with over €1.5 trillion AUM leveraging the Danish Compromise for capital efficiency.

Discover the global motor insurance market trends, AI-driven risk assessment, regulatory shifts, and regional insights shaping insurance innovation and growth through 2032.

New York State audit finds over $1.5 million in Anthem Blue Cross overpayments for physician-administered drugs under the Empire Plan, highlighting ongoing oversight and claims management challenges.

The Supreme Court upholds the preventive services task force under the ACA, maintaining no-cost coverage of key health screenings and interventions affecting millions of insured Americans.

UnitedHealth Group's stock has dropped over 50% in 2024 amid operational disruptions and DOJ probes, despite strong ROCE. Insights on regulatory risks, Medicare cost pressures, and valuation outlook for investors.

The Supreme Court's 2025 ruling affirms ACA preventive service coverage, shaping pharmaceutical, diagnostic, and insurance sector investments amid evolving HHS regulations.

Novo Nordisk expands access to Wegovy with a new self-pay pricing program and pursues legal actions against unauthorized compounded drug sales, impacting the obesity treatment market.